Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 3
1994 1
1995 1
1996 2
1997 3
1998 3
1999 4
2000 6
2001 3
2002 7
2003 4
2004 2
2005 2
2006 1
2008 2
2009 3
2010 1
2011 2
2012 3
2013 4
2014 1
2015 4
2016 6
2017 6
2018 6
2019 8
2020 7
2021 7
2022 11
2023 12
2024 19
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration.
Beukenhorst AL, Frallicciardi J, Rice KL, Koldijk MH, Moreira de Mello JC, Klap JM, Hadjichrysanthou C, Koch CM, da Costa KAS, Temperton N, de Jong BA, Vietsch H, Ziere B, Julg B, Koudstaal W, Goudsmit J. Beukenhorst AL, et al. Among authors: de jong ba. Sci Rep. 2024 Feb 15;14(1):3818. doi: 10.1038/s41598-024-53049-5. Sci Rep. 2024. PMID: 38360813 Free PMC article.
[Treatment of multiple sclerosis].
Meijs N, De Jong BA, Van Oosten BW, Strijbis EMM. Meijs N, et al. Among authors: de jong ba. Ned Tijdschr Geneeskd. 2024 May 6;168:D7617. Ned Tijdschr Geneeskd. 2024. PMID: 38747608 Dutch.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
Toorop AA, van Lierop ZY, Gelissen LM, Hoitsma E, Zeinstra EM, van Rooij LC, van Munster CE, Vennegoor A, Mostert JP, Wokke BH, Kalkers NF, Hoogervorst EL, van Eijk JJ, Roosendaal CM, Kragt JJ, Eurelings M, van Genugten J, Nielsen J, Sinnige L, Kloosterziel ME, Arnoldus EP, van Dijk GW, Bouvy WH, Wessels MH, Boonkamp L, Strijbis EM, van Oosten BW, De Jong BA, Lissenberg-Witte BI, Barkhof F, Moraal B, Teunissen CE, Rispens T, Uitdehaag BM, Killestein J, van Kempen ZL. Toorop AA, et al. Among authors: de jong ba. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):392-400. doi: 10.1136/jnnp-2023-332119. J Neurol Neurosurg Psychiatry. 2024. PMID: 37963723 Clinical Trial.
On autonomy and participation in rehabilitation.
Cardol M, De Jong BA, Ward CD. Cardol M, et al. Among authors: de jong ba. Disabil Rehabil. 2002 Dec 15;24(18):970-4; discussion 975-1004. doi: 10.1080/09638280210151996. Disabil Rehabil. 2002. PMID: 12528676 Review.
Don't be late! Postponing cognitive decline and preventing early unemployment in people with multiple sclerosis: a study protocol.
Aarts J, Saddal SRD, Bosmans JE, de Groot V, de Jong BA, Klein M, Ruitenberg MFL, Schaafsma FG, Schippers ECF, Schoonheim MM, Uitdehaag BMJ, van der Veen S, Waskowiak PT, Widdershoven GAM, van der Hiele K, Hulst HE; Don’t be late! consortium. Aarts J, et al. Among authors: de jong ba. BMC Neurol. 2024 Jan 15;24(1):28. doi: 10.1186/s12883-023-03513-y. BMC Neurol. 2024. PMID: 38225561 Free PMC article.
Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial.
Nauta IM, van Dam M, Bertens D, Kessels RPC, Fasotti L, Uitdehaag BMJ, Speckens AEM, de Jong BA. Nauta IM, et al. Among authors: de jong ba. J Neurol. 2024 Jul;271(7):4361-4372. doi: 10.1007/s00415-024-12327-y. Epub 2024 Apr 23. J Neurol. 2024. PMID: 38653820 Free PMC article. Clinical Trial.
Recent advances in rehabilitation.
Wade DT, de Jong BA. Wade DT, et al. Among authors: de jong ba. BMJ. 2000 May 20;320(7246):1385-8. doi: 10.1136/bmj.320.7246.1385. BMJ. 2000. PMID: 10818031 Free PMC article. Review. No abstract available.
Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis.
Molenaar PCG, Noteboom S, van Nederpelt DR, Krijnen EA, Jelgerhuis JR, Lam KH, Druijff-van de Woestijne GB, Meijer KA, van Oirschot P, de Jong BA, Brouwer I, Jasperse B, de Groot V, Uitdehaag BMJ, Schoonheim MM, Strijbis EMM, Killestein J. Molenaar PCG, et al. Among authors: de jong ba. J Neurol. 2024 Sep;271(9):5958-5968. doi: 10.1007/s00415-024-12516-9. Epub 2024 Jul 15. J Neurol. 2024. PMID: 39008036 Free PMC article.
Prevalence and incidence of multiple sclerosis in the Netherlands.
Lemmens CMC, Vanhommerig JW, Knottnerus BJ, Uitdehaag BMJ, Mostert JP, de Jong BA. Lemmens CMC, et al. Among authors: de jong ba. Mult Scler Relat Disord. 2024 Dec 1;93:106207. doi: 10.1016/j.msard.2024.106207. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39657510 Free article.
129 results